"A group medical practice specializing in diseases of the kidney. Renal Associates has 13 nephrologist and 8 nurse practitioners who collaborate to ensure excellent service for the individuals we care for."

During the past decade, Renal Associates of Baton Rouge conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renal Associates of Baton Rouge" #1 sponsor was "Reata Pharmaceuticals, Inc." with 3 trials, followed by "Prokidney" with 2 trials sponsored, "Shire" with 2 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 2 trials sponsored and "Ardelyx" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renal Associates of Baton Rouge" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Renal Associates of Baton Rouge" are "Chronic Kidney Disease" (3 trials), "Autosomal Dominant Polycystic Kidney" (2 trials), "Chronic Kidney Diseases" (2 trials), "Hyperphosphatemia" (2 trials) and "ADPKD" (1 trials). Many other conditions were trialed in "Renal Associates of Baton Rouge" in a lesser frequency.

Most popular intervention types in "Renal Associates of Baton Rouge" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bardoxolone methyl oral capsule" (2 trials), "Placebo oral capsule" (2 trials), "Renal Autologous Cell Therapy (REACT)" (2 trials) and "Sevelamer hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Renal Associates of Baton Rouge" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Renal Associates of Baton Rouge". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Renal Associates of Baton Rouge, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Renal Associates of Baton Rouge, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".